Lavita AI operates a decentralized, patient-driven health information marketplace hosted on the Theta Metachain that combines privacy-preserving computation with advanced AI. The platform returns ownership and control of health data to individuals and enables them to securely share and monetize their data via LAVITA TNT-20 tokens. Lavita’s product roadmap includes clinical-trial matching, convening data cohorts for large-scale genome- and phenome-wide studies, secure multi-party data sharing for drug discovery, and tools for health institutions to train and fine-tune domain-specific LLMs. The company is integrating Theta Edge Network for distributed computation and storage to support healthcare model training and a custom Theta subchain for private clinical-trial matching. Lavita closed a $5M seed financing to accelerate development of its AI-first platform and applications for patients, providers, and research institutions. The company was selected for the Microsoft for Startups Founders Hub Program and has published a white paper describing its approach.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

May 2023